Radiotherapy utilization in developing countries: An IAEA study
| Autor: | Lisbeth Cordero, Primoz Strojan, Eduardo Rosenblatt, Michael Barton, Eduardo Zubizarreta, Suzana Stojanovic-Rundic, Joel Yarney, Glenn W. Jones, William J. Mackillop, John V. Gan, Elena Fidarova, Gerard Lim, Lotfi Kochbati, Valentin Cernea, Aldo Quarneti |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
Pediatrics medicine.medical_specialty medicine.medical_treatment Utilization rates Medically Underserved Area Developing country Radiation oncology 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Rate difference Neoplasms Epidemiology of cancer Epidemiology medicine Humans Radiology Nuclear Medicine and imaging Developing Countries Radiotherapy business.industry Incidence Incidence (epidemiology) Cancer Hematology Middle Aged medicine.disease Radiation therapy Oncology 030220 oncology & carcinogenesis Income Female business Limited resources Needs Assessment |
| Zdroj: | Radiotherapy and Oncology. 128:400-405 |
| ISSN: | 0167-8140 |
| DOI: | 10.1016/j.radonc.2018.05.014 |
| Popis: | Background: The planning of national radiotherapy (RT) services requires a thorough knowledge of the country’s cancer epidemiology profile, the radiotherapy utilization (RTU) rates and a future projection of these data. Previous studies have established RTU rates in high-income countries. Methods: Optimal RTU (oRTU) rates were determined for nine middle-income countries, following the epidemiological evidence-based method. The actual RTU (aRTU) rates were calculated dividing the total number of new notifiable cancer patients treated with radiotherapy in 2012 by the total number of cancer patients diagnosed in the same year in each country. An analysis of the characteristics of patients and treatments in a series of 300 consecutive radiotherapy patients shed light on the particular patient and treatments profile in the participating countries. Results: The median oRTU rate for the group of nine countries was 52% (47–56%). The median aRTU rate for the nine countries was 28% (9–46%). These results show that the real proportion of cancer patients receiving RT is lower than the optimal RTU with a rate difference between 10–42.7%. The median percent-unmet need was 47% (18–82.3%). Conclusions: The optimal RTU rate in middle-income countries did not differ significantly from that previously found in high-income countries. The actual RTU rates were consistently lower than the optimal, in particular in countries with limited resources and a large population. Crown Copyright 2018 Published by Elsevier B.V. All rights reserved. Radiotherapy and Oncology 128 (2018) 400–405 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect